n 15 Pill - blue round, 7mm
Pill with imprint n 15 is Blue, Round and has been identified as Morphine Sulfate Extended-Release 15 mg. It is supplied by Novel Laboratories, Inc.
Morphine is used in the treatment of Chronic Pain; Neonatal Abstinence Syndrome; Pain and belongs to the drug class Opioids (narcotic analgesics). Risk cannot be ruled out during pregnancy. Morphine 15 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for n 15
Morphine Sulfate Extended-Release
- Imprint
- n 15
- Strength
- 15 mg
- Color
- Blue
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Opioids (narcotic analgesics)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Novel Laboratories, Inc.
- National Drug Code (NDC)
- 40032-0540
- Inactive Ingredients
-
hydroxyethyl cellulose (4000 mpa.s at 1%),
low substituted hydroxypropyl cellulose,
hypromellose 2208 (100 mPa.s),
lactose monohydrate,
magnesium stearate,
silicon dioxide,
polyvinyl alcohol,
polyethylene glycol 3350,
magnesium silicate,
titanium dioxide,
FD&C Blue No. 2,
FD&C Blue No. 1
Note: Inactive ingredients may vary.
Related images for "n 15"
More about morphine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (367)
- Drug images
- Latest FDA alerts (12)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
Patient resources
- Morphine drug information
- Morphine injection
- Morphine (Epidural) (Advanced Reading)
- Morphine Extended-Release Capsules
- Morphine Immediate-Release Tablets and Capsules
Other brands
MS Contin, Roxanol, Duramorph, Kadian, ... +10 more
Professional resources
- Morphine Sulfate monograph
- Morphine ER (FDA)
- Morphine Extended Release Capsules (FDA)
- Morphine Injection (FDA)
- Morphine Oral Solution (FDA)
Other brands
MS Contin, Duramorph, Kadian, Astramorph PF, ... +4 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.